Coenzyme Q10 Exerts Anti-Inflammatory Activity and Induces Treg in Graft Versus Host Disease

다국어 초록 (Multilingual Abstract)

The objective of this study was to determine whether coenzyme Q10 (CoQ10) can reduce the severity of graft versus host disease (GVHD) by inducing regulatory T cells (Tregs). CoQ10 or vehicle was orally administrated once a day for 22 days to mice with GVHD. We measured the alloresponse of the T cells and the GVHD clinical scores. Real-time polymerase chain reaction was used to examine messenger RNA (mRNA) level. Flow cytometry and enzyme-linked immunosorbent assay were used to evaluate protein expression. CoQ10 reduced the T-cell alloresponse and the expression of interferon (IFN)-γ and interleukin (IL)-17. The severity of GVHD and gene expressions of IL-6 and tumor necrosis factor (TNF)-α decreased with CoQ10 treatment. Furthermore, CoQ10 promoted weight gain and survival in GVHD mice. Flow cytometry revealed that CoQ10 dose dependently induced Treg differentiation, but FK506, an immunosuppressive drug, decreased Treg differentiation dose dependently. In conclusion, CoQ10 downregulates the alloreactivity of T cells and reduces GVHD severity, enhancing the differentiation of Tregs.

참고문헌 (Reference)

1 Remberger M, "alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD" 15 : 99-104, 1995

2 Jacobsohn DA, "Weight loss and malnutrition in patients with chronic graft-versus-host disease" 29 : 231-236, 2002

3 Blazar BR, "Vallera DA : Recent advances in graftversus-host disease(GVHD)prevention" 157 : 79-109, 1997

4 Suh JH, "Thiol/redox metabolomic profiling implicates GSH dysregulation in early experimental graft versus host disease (GVHD)" 9 : e88868-, 2014

5 Symington FW, "The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation" 54 : 457-462, 1992

6 Amer J, "The oxidative status of blood cells in a murine model of graft-versus-host disease" 86 : 753-758, 2007

7 Liu Y, "The expression of Th17-associated cytokines in human acute graft-versus-host disease" 19 : 1421-1429, 2013

8 Miwa Y, "Tacrolimus-induced lung injury in a rheumatoid arthritis patient with interstitial pneumonitis" 18 : 208-211, 2008

9 Dai YL, "Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction:A randomized controlled trial" 216 : 395-401, 2011

10 Singer BD, "Regulatory T cells as immunotherapy" 5 : 46-, 2014

11 Cahn JY, "Prospective evaluation of 2acute graft-versus-host (GVHD) grading systems: A joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGMTC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study" 106 : 1495-1500, 2005

12 Fukui J, "Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells" 25 : 1595-1601, 2007

13 Azar Y, "Preimplantation factor reduces graft-versus-host disease by regulating immune response and lowering oxidative stress (murine model)" 19 : 519-528, 2013

14 Kumagai S, "Pathological roles of oxidative stress in autoimmune diseases" 51 : 126-132, 2003

15 Zhu H, "Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: Updated experimental and clinical evidence" 237 : 474-480, 2012

16 Le Moine A, "Multiple pathways to allograft rejection" 73 : 1373-1381, 2002

17 Perez-Sanchez C, "Mitochondrial dysfunction in antiphospholipid syndrome: Implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatment" 119 : 5859-5870, 2012

18 Korngold R, "Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow" 148 : 1687-1698, 1978

19 Lin Q, "Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation [in Chinese]" 25 : 1261-1265, 2006

20 Holler E, "Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation" 75 : 1011-1016, 1990

21 Malard F, "Increased Th17/Treg ratio in chronic liver GVHD" 49 : 539-544, 2014

22 Corthay A, "How do regulatory T cells work?" 70 : 326-336, 2009

23 Shlomchik WD, "Graft-versus-host disease" 7 : 340-352, 2007

24 Auer DE, "Free radical oxidation products in plasma and synovial fluid of horses with synovial inflammation" 70 : 49-52, 1993

25 Blazar BR, "FK506inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation" 153 : 1836-1846, 1994

26 Chiasson VL, "FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension" 57 : 1167-1175, 2011

27 Krenger W, "Dysregulation of cytokines during graftversus-host disease" 5 : 3-14, 1996

28 Duran-Prado M, "Coenzyme Q10 protects human endothelial cells from beta-amyloid uptake and oxidative stress-induced injury" 9 : e109223-, 2014

29 Lee J, "Coenzyme Q10 ameliorates pain and cartilage degradation in a rat model of osteoarthritis by regulating nitric oxide and inflammatory cytokines" 8 : e69362-, 2013

30 Naesens M, "Calcineurin inhibitor nephrotoxicity" 4 : 481-508, 2009

31 Brownlee M, "Biochemistry and molecular cell biology of diabetic complications" 414 : 813-820, 2001

32 Zhang Y, "Alloreactive memory T cells are responsible for the persistence of graftversus-host disease" 174 : 3051-3058, 2005

33 Socie G, "Acute graft-versus-host disease: From the bench to the bedside" 114 : 4327-4336, 2009